nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—HTR2A—chronic obstructive pulmonary disease	0.726	1	CbGaD
Remoxipride—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0674	0.346	CbGbCtD
Remoxipride—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0674	0.346	CbGbCtD
Remoxipride—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0601	0.308	CbGbCtD
Remoxipride—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.0196	0.481	CbGeAlD
Remoxipride—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00711	0.175	CbGeAlD
Remoxipride—Amisulpride—HTR2A—chronic obstructive pulmonary disease	0.00236	1	CrCbGaD
Remoxipride—SIGMAR1—bronchus—chronic obstructive pulmonary disease	0.00185	0.0454	CbGeAlD
Remoxipride—DRD2—respiratory system—chronic obstructive pulmonary disease	0.00181	0.0445	CbGeAlD
Remoxipride—SIGMAR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00181	0.0444	CbGeAlD
Remoxipride—SIGMAR1—trachea—chronic obstructive pulmonary disease	0.00166	0.0407	CbGeAlD
Remoxipride—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.0012	0.0294	CbGeAlD
Remoxipride—SIGMAR1—lung—chronic obstructive pulmonary disease	0.00119	0.0293	CbGeAlD
Remoxipride—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.00105	0.0259	CbGeAlD
Remoxipride—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000963	0.0237	CbGeAlD
Remoxipride—DRD2—lung—chronic obstructive pulmonary disease	0.000963	0.0236	CbGeAlD
Remoxipride—HTR2A—trachea—chronic obstructive pulmonary disease	0.000884	0.0217	CbGeAlD
Remoxipride—HTR2A—lung—chronic obstructive pulmonary disease	0.000635	0.0156	CbGeAlD
Remoxipride—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00019	0.00528	CbGpPWpGaD
Remoxipride—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000188	0.00521	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000185	0.00514	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000184	0.00512	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000184	0.0051	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000183	0.00508	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000179	0.00498	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000177	0.00492	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000165	0.00459	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000164	0.00457	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000164	0.00455	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000157	0.00437	CbGpPWpGaD
Remoxipride—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.00428	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000151	0.0042	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.00014	0.0039	CbGpPWpGaD
Remoxipride—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00384	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000138	0.00384	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000137	0.00381	CbGpPWpGaD
Remoxipride—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00379	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000135	0.00374	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00013	0.0036	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000126	0.0035	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000125	0.00348	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00012	0.00334	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00012	0.00333	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000118	0.00329	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000115	0.0032	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000115	0.00319	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000115	0.00318	CbGpPWpGaD
Remoxipride—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.00311	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000111	0.00308	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00011	0.00307	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000107	0.00298	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000102	0.00284	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000101	0.00281	CbGpPWpGaD
Remoxipride—HTR2A—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.0001	0.00278	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	9.92e-05	0.00276	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	9.86e-05	0.00274	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.86e-05	0.00274	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	9.81e-05	0.00272	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.74e-05	0.00271	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	9.52e-05	0.00264	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	9.45e-05	0.00262	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	9.16e-05	0.00254	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	9.03e-05	0.00251	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	9.01e-05	0.0025	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9e-05	0.0025	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	8.96e-05	0.00249	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	8.81e-05	0.00245	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	8.81e-05	0.00245	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	8.68e-05	0.00241	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	8.67e-05	0.00241	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	8.58e-05	0.00238	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	8.46e-05	0.00235	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.39e-05	0.00233	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	8.19e-05	0.00227	CbGpPWpGaD
Remoxipride—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	8.08e-05	0.00224	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	8.02e-05	0.00223	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	7.82e-05	0.00217	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.71e-05	0.00214	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.62e-05	0.00212	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	7.62e-05	0.00212	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	7.56e-05	0.0021	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	7.55e-05	0.0021	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.51e-05	0.00209	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.5e-05	0.00208	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	7.43e-05	0.00206	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	7.38e-05	0.00205	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	7.28e-05	0.00202	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.92e-05	0.00192	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.89e-05	0.00191	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.83e-05	0.0019	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.77e-05	0.00188	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	6.75e-05	0.00187	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.74e-05	0.00187	CbGpPWpGaD
Remoxipride—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.74e-05	0.00187	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.71e-05	0.00186	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	6.69e-05	0.00186	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.64e-05	0.00184	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	6.61e-05	0.00184	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.42e-05	0.00178	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	6.32e-05	0.00176	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.28e-05	0.00174	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	6.26e-05	0.00174	CbGpPWpGaD
Remoxipride—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.19e-05	0.00172	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.14e-05	0.00171	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	6.13e-05	0.0017	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	6.01e-05	0.00167	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	5.99e-05	0.00166	CbGpPWpGaD
Remoxipride—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.95e-05	0.00165	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.94e-05	0.00165	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.9e-05	0.00164	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.87e-05	0.00163	CbGpPWpGaD
Remoxipride—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.87e-05	0.00163	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.83e-05	0.00162	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.75e-05	0.0016	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.74e-05	0.00159	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.66e-05	0.00157	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.36e-05	0.00149	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.18e-05	0.00144	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.14e-05	0.00143	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	5.09e-05	0.00141	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	5.08e-05	0.00141	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.07e-05	0.00141	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	5.05e-05	0.0014	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	4.79e-05	0.00133	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.78e-05	0.00133	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.76e-05	0.00132	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.7e-05	0.00131	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	4.69e-05	0.0013	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.63e-05	0.00128	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.58e-05	0.00127	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.55e-05	0.00126	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.5e-05	0.00125	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.49e-05	0.00125	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.47e-05	0.00124	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.36e-05	0.00121	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.34e-05	0.00121	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	4.29e-05	0.00119	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.27e-05	0.00119	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.24e-05	0.00118	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	4.17e-05	0.00116	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.09e-05	0.00113	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.08e-05	0.00113	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.88e-05	0.00108	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.85e-05	0.00107	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.81e-05	0.00106	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.79e-05	0.00105	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.74e-05	0.00104	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.65e-05	0.00101	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.63e-05	0.00101	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.63e-05	0.00101	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.59e-05	0.000996	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	3.54e-05	0.000983	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.52e-05	0.000977	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.45e-05	0.000957	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.44e-05	0.000957	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.39e-05	0.000942	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.39e-05	0.000942	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.32e-05	0.000922	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.25e-05	0.000902	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3.2e-05	0.000888	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.19e-05	0.000885	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.17e-05	0.000881	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	3.09e-05	0.000857	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.01e-05	0.000837	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.99e-05	0.00083	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.95e-05	0.000819	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.92e-05	0.00081	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.9e-05	0.000806	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.9e-05	0.000806	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.87e-05	0.000797	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.86e-05	0.000793	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.78e-05	0.000771	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.78e-05	0.000771	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.78e-05	0.000771	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.73e-05	0.000759	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.73e-05	0.000759	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	2.72e-05	0.000756	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.65e-05	0.000737	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.64e-05	0.000732	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.59e-05	0.00072	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.56e-05	0.000712	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.54e-05	0.000705	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.47e-05	0.000685	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.31e-05	0.000641	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.31e-05	0.00064	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.29e-05	0.000636	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.28e-05	0.000632	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.000582	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.08e-05	0.000578	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.05e-05	0.000569	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.03e-05	0.000565	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.03e-05	0.000564	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2e-05	0.000557	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2e-05	0.000555	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.89e-05	0.000524	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.86e-05	0.000517	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.86e-05	0.000517	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.86e-05	0.000516	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.85e-05	0.000514	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.78e-05	0.000494	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.74e-05	0.000484	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.71e-05	0.000476	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.69e-05	0.000468	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.67e-05	0.000463	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.65e-05	0.00046	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.57e-05	0.000436	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.56e-05	0.000432	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.54e-05	0.000429	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.53e-05	0.000425	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.53e-05	0.000425	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.52e-05	0.000422	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.46e-05	0.000406	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.42e-05	0.000396	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.42e-05	0.000393	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.4e-05	0.000389	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.4e-05	0.000389	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.000388	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.39e-05	0.000387	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.36e-05	0.000378	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.36e-05	0.000378	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.3e-05	0.000361	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.27e-05	0.000352	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.25e-05	0.000346	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.24e-05	0.000344	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.24e-05	0.000344	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.18e-05	0.000327	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.17e-05	0.000324	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.00032	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.12e-05	0.000311	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.1e-05	0.000305	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000298	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.05e-05	0.00029	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.04e-05	0.000289	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.02e-05	0.000285	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.02e-05	0.000283	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.01e-05	0.000279	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.95e-06	0.000276	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.94e-06	0.000276	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.78e-06	0.000272	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.49e-06	0.000263	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.33e-06	0.000259	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.23e-06	0.000256	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.05e-06	0.000251	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.93e-06	0.000248	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.41e-06	0.000234	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.28e-06	0.00023	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.2e-06	0.000228	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.04e-06	0.000223	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8e-06	0.000222	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.87e-06	0.000219	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.61e-06	0.000211	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.6e-06	0.000211	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.49e-06	0.000208	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.95e-06	0.000193	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	6.92e-06	0.000192	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.83e-06	0.00019	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.75e-06	0.000187	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.72e-06	0.000187	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	6.62e-06	0.000184	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.27e-06	0.000174	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.18e-06	0.000172	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.17e-06	0.000171	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.15e-06	0.000171	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.05e-06	0.000168	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.16e-06	0.000143	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.08e-06	0.000141	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.73e-06	0.000131	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.65e-06	0.000129	CbGpPWpGaD
